WallStSmart
BCDA

Biocardia Inc

NASDAQ: BCDA · HEALTHCARE · BIOTECHNOLOGY

$1.10
-3.51% today

Updated 2026-04-29

Market cap
$12.69M
P/E ratio
P/S ratio
2,520.59x
EPS (TTM)
$-1.23
Dividend yield
52W range
$1 – $3
Volume
0.1M

Biocardia Inc (BCDA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-741464.00$-47123.00$-2.70M$-4.78M$-4.28M$-3.09M$-310000.00$27000.00$214000.00$331000.00$-5.52M$-8.67M$-11.07M$-9.45M$-12.36M$-10.37M$-10.56M$-9.97M$-8.03M$-7.44M
Capital expenditures$0.00$0.00$515000.00$1.02M$1.07M$137000.00$0.00$27000.00$53000.00$125000.00$136000.00$136000.00$66000.00$146000.00$32000.00$116000.00$70000.00$12000.00$6000.00$7000.00
Depreciation
Stock-based comp$43000.00$107000.00$51000.00$37000.00$6000.00$2000.00$238000.00$283000.00$942000.00$2.71M$2.77M$2.72M$2.95M$1.66M$1.18M$1.03M$741000.00$430000.00
Free cash flow$-741464.00$-47123.00$-3.21M$-5.80M$-5.35M$-3.22M$-310000.00$0.00$161000.00$206000.00$-5.66M$-8.81M$-11.13M$-9.59M$-12.39M$-10.48M$-10.63M$-9.99M$-8.03M$-7.44M
Investing cash flow
Financing cash flow
Dividends paid$6.20M$346000.00
Share repurchases
Debt repayment
Net change in cash$27000.00$214000.00$331000.00$17.80M$-8.66M$-7.33M$227000.00$15.82M